Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:3150-3153
doi: 10.1161/hc2501.090955
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moyé, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moyé, L. A.
Related Collections
Right arrow Epidemiology

(Circulation. 2001;103:3150.)
© 2001 American Heart Association, Inc.


Current Perspective

Random Research

Lemuel A. Moyé, MD, PhD

From the University of Texas School of Public Health, Houston, Tex.

Correspondence to Lemuel A. Moyé, MD, PhD, University of Texas School of Public Health, RAS Building E-815, 1200 Herman Pressler, Houston, TX 77030. E-mail lmoye{at}utsph.sph.uth.tmc.edu

Abstract—Advances in computing have combined with the rapid dissemination of treatment discoveries for diseases of public health importance to create pressure for accelerated promulgation of promising research results to the medical community. The 2 recent examples of the US Carvedilol Heart Failure program and the Evaluation of Losartan In the Elderly (ELITE) study demonstrate the importance of the prospective nature of research design, as well as the consequences of its abandonment. This article explains in nonmathematical terms the rationale for the tenet "first say what you will do, then do what you said" in sample-based research.


Key Words: trials • statistics • population • epidemiology




This article has been cited by other articles:


Home page
NEJMHome page
S. S. Rathore, Y. Wang, and H. M. Krumholz
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
N. Engl. J. Med., October 31, 2002; 347(18): 1403 - 1411.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. DeMets and R. M. Califf
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
Circulation, August 13, 2002; 106(7): 880 - 886.
[Full Text] [PDF]


Home page
CirculationHome page
L. A. Moye and A. T.N. Tita
Defending the Rationale for the Two-Tailed Test in Clinical Research
Circulation, June 25, 2002; 105(25): 3062 - 3065.
[Full Text] [PDF]